These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16713806

  • 21. Bisphosphonates--role in cancer therapies.
    Mehrotra B.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract] [Full Text] [Related]

  • 22. Bisphosphonate induced osteonecrosis of the jaw masquerading as tumor: a word of caution for oral surgeons and oncologists.
    Chaturvedi P, Pai PS, Chaukar DA, Gupta S, D'cruz AK.
    Eur J Surg Oncol; 2010 Jun; 36(6):541-5. PubMed ID: 20071132
    [Abstract] [Full Text] [Related]

  • 23. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M, Lawson W, Montazem A.
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [Abstract] [Full Text] [Related]

  • 24. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A, Payne AG, Zafar S.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [Abstract] [Full Text] [Related]

  • 25. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.
    Cartsos VM, Zhu S, Zavras AI.
    J Am Dent Assoc; 2008 Jan; 139(1):23-30. PubMed ID: 18167381
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis.
    Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS.
    J Natl Cancer Inst; 2007 Jul 04; 99(13):1016-24. PubMed ID: 17596574
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May 04; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 32. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N.
    Am J Med; 2010 Nov 04; 123(11):1060-4. PubMed ID: 20851366
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH, Lips P, Eekhoff EM, van Merkesteyn JP, van der Waal I.
    Ned Tijdschr Tandheelkd; 2007 Oct 04; 114(10):423-7. PubMed ID: 17972610
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
    Bagan J, Scully C, Sabater V, Jimenez Y.
    Oral Oncol; 2009 Jul 04; 45(7):551-4. PubMed ID: 19251474
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer.
    Crawford BS, McNulty RM, Kraut EH, Turowski RC.
    Cancer Invest; 2009 Dec 04; 27(10):984-8. PubMed ID: 19909013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.